セッション詳細
[O5]Oral Presentations 5
2026年7月8日(水) 11:10 〜 11:59
伊藤謝恩ホール(伊藤国際学術研究センターB2)
座長:瀬戸口 留可、呉羽 拓
[O5-01]Defining heterogeneous states of aged hematopoietic stem cells and their link with immune cell function
*Atsushi Iwama1 (1. Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo (Japan))
[O5-02]がん・慢性炎症組織の免疫抗原解析
*Shumpei Ishikawa1 (1. Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo (Japan))
[O5-03]ストローマ制御に基づくCOVID-19重症化抑制の新規治療戦略の創出
*Taku Kureha1, Hiroshi Takayanagi1 (1. Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo (Japan))
[O5-04]Understanding and manipulating immune checkpoints in infection, cancer, and autoimmunity
*Taku Okazaki1, Taisuke Narazaki1, Takumi Maruhashi1, Kenji Shimizu1, Il-mi Okazaki1 (1. Laboratory of Molecular Immunology, Institute for Quantitative Biosciences, The University of Tokyo (Japan))
[O5-05]Control of CD8 T cell responses and memory homeostasis by MHC class II molecules
*Ruka Setoguchi1, Shohei Hori1 (1. Laboratory of Immunology and Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo (Japan))
[O5-06]Granulocyte and monocyte precursors constitute a survival niche for long-lived plasma cells in the bone marrow
*Takuya Koike1, Takeshi Inoue1 (1. The UTOPIA Center, The University of Tokyo (Japan))
[O5-07]慢性腎臓病マウスにおけるSARS-CoV-2感染への脆弱性と老化細胞との関連
*Yoshimi Imawari1, Sae Aratani1, Hiroshi Ueki2, Naoko Iwata3, Noriyo Nagata3, Yoshihiro Kawaoka2, Makoto Nakanishi1 (1. Division of Cancer Cell Biology, Institute of Medical Science, The University of Tokyo (Japan), 2. Division of Virology, Institute of Medical Science, The University of Tokyo (Japan), 3. Department of Infectious Disease Pathology, National Institute of Infectious Diseases, JIHS (Japan))